scindu funding
All calls

Tools and technologies to support health adaptation to climate change

Horizon Europe · Grant topic

HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03

An independent quality check has put this review on hold. The structured terms below are kept as history and are not cleared; read the official documents.

Summary

A Polish company can use this call for R&D.

Funds innovative tools and technologies for developers, researchers and authorities to prevent climate-related health risks and strengthen healthcare resilience.

Who can apply
Companies can lead: SME, large company, research org, university, public body.
Amount
€4M – €5M per projectTotal budget €20,000,000
Deadline
17 Feb 2027 01:00 CETin 116 days
Status
Forthcomingopens 29 Oct 2026
Open on the portalRegister to keep this call

Machine-classified from the call text; check eligibility at the source.

Description

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment” and the EU Mission on Adaptation to Climate Change. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes:

• Populations, public authorities and healthcare systems benefit from innovative solutions and technologies to increase surveillance and prevention and reduce climatic and environmental health risks.

• Policymakers and public authorities develop and implement environment, climate change and health policies and interventions supported by nearly fit-for-use solutions that can be further upscaled and deployed.

Scope:

Enhancing the adaptive capacity and resilience of healthcare systems and communities is crucial to prevent and reduce the health impacts of climate change. However, many of the urgently needed technologies, tools, systems and solutions are still at an early developmental stage, relying on further support for development and testing. Proposals under this topic are expected to close this gap and build on innovations being developed in the field, supported through, among others, EU Research and Innovation (R&I) funding. In this context, Pre-commercial Procurement (PCP) projects can drive innovation and speed up the development of technologies for health adaptation to climate change by supporting the research and development of solutions to increase the resilience and preparedness of healthcare systems, communities and individuals against climate change. By focusing on early-stage solutions, PCP fosters collaboration between public sector buyers (e.g. public authorities, local authorities, health organisations) and private developers to create climate adaptation technologies, systems and solutions in the context of human health. These solutions will accelerate the transition to more climate-resilient healthcare systems and societies.

PCP actions target consortia of procurers with similar needs that want to jointly procure the development of innovative solutions for supporting adaptation efforts. This topic does not provide direct funding to developers, industry or research organisations to perform Research and Development (R&D). They will be able to respond to the call for tenders launched by consortia of procurers funded under this topic.

Proposals under this topic should support the development of innovative solutions, tools and models to enhance surveillance, prediction, prevention, risk management and diagnosis (e.g. testing), supporting the adaptation, resilience, and preparedness of healthcare systems and populations to climatic and climate-related environmental health risks.

More specifically proposals can support any of the areas listed below:

• Geospatial technologies and decision-support frameworks that help local authorities and healthcare providers track at “high resolution” and better manage direct and indirect health risks related to climate change.

• Real-time risk surveillance and early-warning technologies and monitoring tools that provide critical information for timely decision-making and responses related to the health risks of climate change.

• Technologies and solutions that facilitate the transition to climate-resilient healthcare facilities and services. Activities targeting the general infrastructure (e.g. ventilation, construction or refurbishment) are out of scope.

• Technologies, tools, procedures and solutions for health risk management, prevention and resilience, enhancing strategies and interventions for health adaptation to climate change in communities and occupational settings.

• Innovative tools reducing risk and exposure to climate related environmental factors that exacerbate health risks.

This topic considers tools and technologies that could be developed and tested to support adaptation at both the community and healthcare system levels[1]. This approach would comprehensively address the needs of health authorities and those of local authorities and public organisations involved in risk management. Consortium composition could include diverse stakeholders such as hospitals, primary healthcare providers, domestic care services, municipalities, civil protection entities and government agencies. The focus can extend beyond climate variables to include other related environmental and ecological factors (for example air pollution) that interact with climate change and impact public health.

Proposals are encouraged to consider, where relevant, the data, expertise and services offered by European research infrastructures[2] in the environment, climate and health domain.

Continuous dialogue between demand and supply side is required for the success of PCPs, therefore the effective involvement of end users should be considered in the proposal.

Involvement of procurement decision makers is needed to ensure that end solution(s) are adopted by healthcare systems and/or local authorities and public organisations increasing the societal impact of the related research activities. Therefore, procurers should declare in the proposal their interest to purchase at least one solution resulting from the PCP in case the PCP delivers successful solutions and indicate whether they will i) procure the solution(s) as part of the PCP or ii) in a separate follow-up procurement after the PCP. In the first case, procurers can implement the project as a fast-track PCP (see section H of the General Annexes of this Work Programme for further details) and foresee the budget to purchase at least one solution during the PCP. In the second case, the procurers should include in the proposal a deliverable that prepares the follow-up procurement to purchase successful solution(s) after the PCP.

This topic is co-financed by the EU Mission on Adaptation to climate change[3] and supports the follow up to the 2023 Communication on the Missions[4]. Projects are encouraged to channel their activities through the Mission Implementation Platform[5] and the Mission’s Community of Practice[6].

[1] For digital technologies concerned, appropriate measures for the security of the communications between the intended parties should be considered, in particular based on the use of post-quantum cryptography.

[2] The catalogue of European Strategy Forum on Research Infrastructures (ESFRI) research infrastructures portfolio can be browsed on the ESFRI website: https://ri-portfolio.esfri.eu

[3] https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe/eu-missions-horizon-europe/adaptation-climate-change_en

[4] https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52023DC0457&qid=1693304388860

[5] Initially established by MIP4Adapt (https://climate-adapt.eea.europa.eu/en/mission/the-mission/about-mip4adapt, https://fedarene.org/project/mip4adapt) and extended under the contract CINEA/2025/OP/0014.

[6] https://climate-adapt.eea.europa.eu/en/mission/community-of-practice

Who can apply, in detail
Applicant types
SME, Large company, Research org, University, Public body
Purpose
Research and innovation
R&D relevance
3 of 3
Poland eligible
Yes
Country limit
—
Region
Any
Consortium
Unclear
Readiness level (TRL)
—
Topics
  • Climate adaptation
  • Environmental health
  • Health surveillance
  • Healthcare resilience

Machine-classified from the call text; check eligibility at the source. 23 Oct 2026

Conditions20

Typed facts extracted from the source documents by Scindu's grant-data review. Each value keeps its own conditions. Unknown means unstated, not zero or unlimited.

Applicant restrictionQA hold
General Annex B restrictive-measures and participant exclusions apply; China-specific RIA/IA restrictions are not reclassified as a blanket PCP prohibition.
Applicant restrictionQA hold
The topic does not directly fund developers, industry or research organisations to perform R&D; they compete for supplier contracts. Providers cannot be grant beneficiaries in the action planning/undertaking the PCP.
Applicant typeQA hold
Legal entities subject to Horizon Europe Regulation, General Annex B and topic-specific conditions; participation does not itself establish eligibility for funding.
Application restrictionQA hold
Conduct and report an open-market consultation before procurement; widely advertise tenders in EU/Associated Countries. Joint PCP uses one joint tender/evaluation and a lead procurer. The PCP tender must remain open for at least60days.
Application restrictionQA hold
Planned opening 2026-10-29; single-stage deadline 2027-02-17, 17:00 Brussels local time. Work Programme allows opening shifts and deadline delays; live acceptance is not verified.
Application restrictionQA hold
Declare interest in purchasing at least one successful PCP solution; specify purchase during fast-track PCP with a budget or prepare a follow-up procurement deliverable.
Consortium requiredQA hold
Yes
Eligible geographyQA hold
General Annex B funding-geography conditions apply, with the topic-specific exception allowing US legal entities to receive Union funding. Participation and funded status remain distinct; restrictive measures and applicant-specific conditions still apply.
Eligible project scopeQA hold
Consortia of procurers jointly procure development of tools/technologies for climate-related health adaptation, including surveillance, prediction, prevention, risk management and diagnosis. Developers/industry/research organisations obtain R&D contracts through procurement rather than direct grant funding under this topic. General healthcare infrastructure construction/refurbishment is excluded.
Ineligible project scopeQA hold
General infrastructure activities such as ventilation, construction or refurbishment are excluded.
Other conditionQA hold
The exact topic adopts General Annex G, subject to its expressly listed exceptions. The signed grant fixes the final amount, eligible costs, model, duration and reporting arrangements.
Other conditionQA hold
Project starting date and duration are fixed in the grant agreement. No numerical duration is asserted from the indicative funding table.
Other conditionQA hold
The reviewed own-topic setup does not state a lump-sum exception. For actual-cost grants General Annex G provides a mixed budget reimbursing eligible actual costs with applicable unit/flat-rate categories; the operative grant controls the model.
Other conditionQA hold
Own-topic overview plans an indicative 4 projects expected to be funded; not job headcount or consortium size. Dedicated numeric semantic proposal is supplied separately.
Other conditionQA hold
PCP covers solution design, prototyping, original development and testing. Normally select at least3providers at start; AnnexH permits a stated exceptional two-tenderer case when fewer than2can perform R&D in the required geography. Best-value criteria, IPR/risk-benefit sharing and conflict avoidance apply.
Other conditionQA hold
The granting authority may object to transfer of ownership or exclusive licensing of results up to four years after action end, under the specific Annex5 provision.
Other conditionQA hold
When satellite observation, positioning, navigation or related timing data/services are used, use Copernicus and/or Galileo/EGNOS; other services/data may be additional.
Partner requirementQA hold
At least three independent beneficiary legal entities in three different countries: at least one in an EU Member State and at least two others in different EU Member States or Associated Countries. Affiliated entities do not count toward this minimum.
Partner requirementQA hold
In addition to the general three-independent-beneficiary rule, at least two beneficiaries must be independent public procurers in different Member/Associated countries, including at least one Member State; other entities may contribute justified additional activities without conflict.
Staff restrictionQA hold
Subcontracted work must take place in the EU/Associated Countries unless the granting authority approves otherwise. AnnexH also requires majority R&D activities and principal researchers in Member/Associated Countries; this is a supplier-performance location rule, not a new-hire requirement.
Amounts and costs7
Indicative budget
€20,000,000

Topic budget as stated in the portal's budget table. Lump-sum and per-project limits are in the call conditions.

Funding per beneficiary, maximumQA hold
€60,000

Financial support for deployment/impact, grants only, under AnnexH; not cap on the main consortium grant.

Eligible costQA hold
PCP procurement costs are eligible under the adopted AnnexH conditions.
Eligible costQA hold
General Annex G includes personnel costs, subcontracting and purchases among eligible budget categories subject to the grant agreement. Personnel may use applicable actual-cost or unit-cost forms. This is a cost category, not an advertised vacancy, mandatory hire, salary scale, headcount or FTE entitlement.

For the explicit lump-sum topic, eligible personnel estimates help establish the lump sum; salary reimbursement is not asserted.

Funding intensity, maximumQA hold
100 percent of eligible costs

General Annex G maximum for the actual action type; signed-grant eligible-cost/model conditions apply. For lump sums the rate is part of amount setting.

Expected project funding, up toQA hold
€5,000,000

Indicative expected contribution range; requests for different amounts may be submitted and selected. Not a hard minimum/cap.

Expected project funding, fromQA hold
€4,000,000

Indicative expected contribution range; requests for different amounts may be submitted and selected. Not a hard minimum/cap.

Topic allocationQA hold
€20,000,000

Indicative total topic budget; not an individual cap, guaranteed award or current remaining balance.

Source documents2
Call facts
Opens
29 Oct 2026
Deadline model
Single-stage
Programme
Horizon Europe · 2021 - 2027
Call
HORIZON-HLTH-2027-01 · Cluster 1 - Health (Single stage - 2027/1)
Types of action
HORIZON Pre-commercial Procurement
Keywords
  • Climate
  • Climate adaptation
  • Climate interventions
  • Early-warning systems
  • Health
  • Preparedness
  • Resilience
  • Tools and solutions
Checked
24 Oct 2026
Portal updated
7 Oct 2026
Review status
Partial review
Independent QA
On hold
Reviewed
23 Oct 2026

This is a summary of the source page, not the official text. Eligibility, conditions and the submission system are at the source.